阿柔比星与重氮醌治疗晚期小细胞支气管癌的II期研究（EST 4581）：一项东部肿瘤协作组研究 - Suppr | 超能文献

Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.

作者信息

Abeloff M D, Finkelstein D M, Chang A Y, Camacho F J, Creech R H, Ettinger D S

出版信息

Cancer Treat Rep. 1985 Apr;69(4):451-2.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.阿柔比星与重氮醌治疗晚期小细胞支气管癌的II期研究（EST 4581）：一项东部肿瘤协作组研究

Cancer Treat Rep. 1985 Apr;69(4):451-2.

2

Phase II clinical trial of diaziquone in bronchogenic carcinoma.

Cancer Treat Rep. 1985 Jul-Aug;69(7-8):921-2.

3

Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.米托蒽醌、阿柔比星和二嗪醌治疗非小细胞肺癌的II期研究：东部肿瘤协作组的一项研究

Cancer Treat Rep. 1985 Sep;69(9):1033-4.

4

Phase II study of diaziquone in patients with advanced carcinoma of the lung.重氮醌用于晚期肺癌患者的II期研究。

Cancer Treat Rep. 1984 Sep;68(9):1193-4.

5

Phase I-II diaziquone chemotherapy in brain tumors.

Cancer Treat Rep. 1984 Jun;68(6):913-4.

6

Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.氮烯醌用于蒽环类耐药成年软组织和骨肉瘤患者的II期试验：一项东南癌症研究组试验

Cancer Treat Rep. 1986 Mar;70(3):427-8.

7

Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.重氮醌用于晚期软组织和骨肉瘤的II期研究：一项西南肿瘤协作组的研究

Cancer Treat Rep. 1985 Sep;69(9):1035-6.

8

Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).癌症与白血病B组二期非小细胞肺癌试验：氮丙啶基苯醌（AZQ）。

Cancer Treat Rep. 1983 Jan;67(1):95-6.

9

Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.重氮醌用于胰腺癌的II期评估：西南肿瘤学组研究

Cancer Treat Rep. 1987 Dec;71(12):1309-10.

10

Aclarubicin given as continuous infusion in non-small cell bronchogenic carcinoma.阿柔比星持续输注治疗非小细胞支气管癌。

Cancer Treat Rep. 1985 Nov;69(11):1327-8.

引用本文的文献

1

In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).阿柔比星治疗肺小细胞癌（SCCL）潜力的体外评估。

Br J Cancer. 1989 Dec;60(6):838-44. doi: 10.1038/bjc.1989.376.

2

Phase II study of high-dose aclarubicin in previously treated patients with small-cell lung cancer.高剂量阿柔比星用于既往接受过治疗的小细胞肺癌患者的II期研究。

Cancer Chemother Pharmacol. 1992;30(3):219-20. doi: 10.1007/BF00686316.